{"id":309736,"date":"2026-10-15T10:07:25","date_gmt":"2026-10-15T04:37:25","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=309736"},"modified":"2026-10-15T10:07:25","modified_gmt":"2026-10-15T04:37:25","slug":"concordbio-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/concordbio-best-stock-in-its-sector\/","title":{"rendered":"Is Concord Biotech the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Concord Biotech CMP Rs 1,382 (15 Oct 2026). Market cap Rs 14,449 Cr. ROE 12.94%. P\/E 52.96x versus Industry P\/E 36.77x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Concord Biotech is one of the names investors compare when screening the Pharmaceuticals sector. Whether it is the best stock in its sector depends on whether an investor prioritises return ratios, valuation or balance sheet strength. This article sets it against two named peers and the sector benchmark so you can judge for yourself.<\/p>\n<\/p><\/div>\n

Is Concord Biotech<\/a> the best stock in its sector? The stock trades on the NSE at Rs 1,382 as of 15 October 2026, within its 52-week range of Rs 987.00 to Rs 1,615.00. The sections below cover the business, the key ratios, a peer comparison and a closer look at valuation.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n